Litigation Details for Anacor Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2018)
✉ Email this page to a colleague
Anacor Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-10-17 |
| Court | District Court, D. Delaware | Date Terminated | 2020-09-11 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | GLASSHOUSE PHARMACEUTICALS LIMITED CANADA | ||
| Patents | 7,582,621; 9,549,938; 9,566,289; 9,566,290; 9,572,823 | ||
| Attorneys | Karen Elizabeth Keller | ||
| Firms | JPMorgan Chase & Co. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Anacor Pharmaceuticals, Inc. v. Lupin Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Anacor Pharmaceuticals, Inc. v. Lupin Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-10-17 | 1 | of U.S. Patent No. 9,459,938 (“the ’938 patent”); U.S. Patent No. 9,566,289 (“the ’289 patent”); U.S. …. Patent No. 9,566,290 (“the ’290 patent”); and U.S. Patent No. 9,572,823 (“the ’823 patent”). These…the ’938 patent, the ’290 patent, the ’823 patent, or claims 1–5 or 7–15 of the ’289 patent. …the ’938 patent, the ’290 patent, the ’823 patent, or claims 1–5 or 7–15 of the ’289 patent. …the ’289 patent; claims 2, 5–6, 8, and 11–12 of the ’290 patent; and claim 2 of the ’823 patent. | External link to document | |
| 2021-06-23 | 108 | Report and Recommendations | An ancestor to the patents-in-suit, U.S. Patent No. 7,582,621 (“the ’621 patent”), also claimed methods…of U.S. Patent Nos. 9,549,938, 9,566,289, 9,566,290, and 9,572,823 (collectively, the “patents-in- suit… While the IPR of the ʼ621 patent was pending, the patents-in-suit were being prosecuted before… the four patents-in-suit in early 2017 (before the PTAB’s IPR decision on the ʼ621 patent). Anacor listed…review of the patents-in-suit. The PTAB instituted review of all claims of all four patents-in-suit in | External link to document |
| 2018-10-17 | 4 | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290… 11 September 2020 1:18-cv-01606 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
| 2020-09-11 | 97 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,459,938 B2; 9,566,289 B2; 9,566,290… 11 September 2020 1:18-cv-01606 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
